Considerations in obtaining peanut component tests for establishing the diagnosis of peanut allergy*

Factors that make component testing LESS likely to be informative	Factors that make component testing MORE likely to be informative
A recent convincing clinical reaction	Mild reactions or no reaction history
A remote significant clinical reaction in a patient with PN-IgE ≥15	Remote clinical reaction with development of birch sensitization over time
PN-IgE >25 or <0.35 kU_Α/L	PN-IgE 0.35 to 15 kU_Α/L
Lack of birch sensitization	Birch sensitization
Younger children	Older persons

PN-IgE: peanut-specific immunoglobulin E.
*Obtaining peanut component test results prior to performing a food challenge to peanut is beneficial for risk assessment purposes.

Graphic 95963 Version 2.0

خرید پکیج

Considerations in obtaining peanut component tests for establishing the diagnosis of peanut allergy*